relugolix-话题@MedSci

#relugolix#

10篇内容 | 1339人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2171125, encodeId=068021e11254e, content=<a href='/topic/show?id=53144518948' target=_blank style='color:#2F92EE;'>#子宫肌瘤#</a> <a href='/topic/show?id=07f96056863' target=_blank style='color:#2F92EE;'>#月经过多#</a> <a href='/topic/show?id=b70f1530138' target=_blank style='color:#2F92EE;'>#relugolix#</a>, objectTitle=LIBERTY随机停药研究：relugolix联合疗法治疗子宫肌瘤相关月经量过多, objectType=article, longId=802553, objectId=af9380255369, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/202301012/1697149335278_4754896.jpeg, objectUrl=/article/show_article.do?id=af9380255369, replyNumber=0, likeNumber=92, createdTime=2023-11-26, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=af9380255369, moduleTitle=LIBERTY随机停药研究：relugolix联合疗法治疗子宫肌瘤相关月经量过多, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=af9380255369)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=1573354, encodeId=c4a315e335448, content=<a href='/topic/show?id=b70f1530138' target=_blank style='color:#2F92EE;'>#relugolix#</a>, objectTitle=NEJM：Relugolix联合疗法治疗子宫肌瘤, objectType=article, longId=293031, objectId=0376293031b8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0376293031b8, replyNumber=0, likeNumber=68, createdTime=2021-12-30, rootId=0, userName=juliusluan83, userId=caea15855208, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0376293031b8, moduleTitle=NEJM：Relugolix联合疗法治疗子宫肌瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0376293031b8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1573353, encodeId=68b915e335390, content=<a href='/topic/show?id=b70f1530138' target=_blank style='color:#2F92EE;'>#relugolix#</a>, objectTitle=子宫肌瘤，Relugolix治疗子宫肌瘤显示出潜在的长期益处, objectType=article, longId=293028, objectId=29aa2930283b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=29aa2930283b, replyNumber=0, likeNumber=59, createdTime=2021-12-30, rootId=0, userName=juliusluan83, userId=caea15855208, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=29aa2930283b, moduleTitle=子宫肌瘤，Relugolix治疗子宫肌瘤显示出潜在的长期益处, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=29aa2930283b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1573352, encodeId=498115e3352c7, content=<a href='/topic/show?id=b70f1530138' target=_blank style='color:#2F92EE;'>#relugolix#</a>, objectTitle=子宫肌瘤，Relugolix治疗子宫肌瘤显示出潜在的长期益处, objectType=article, longId=209074, objectId=90de2090e408, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=90de2090e408, replyNumber=0, likeNumber=85, createdTime=2021-03-29, rootId=0, userName=juliusluan83, userId=caea15855208, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=90de2090e408, moduleTitle=子宫肌瘤，Relugolix治疗子宫肌瘤显示出潜在的长期益处, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=90de2090e408)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1573351, encodeId=c4bd15e33516b, content=<a href='/topic/show?id=b70f1530138' target=_blank style='color:#2F92EE;'>#relugolix#</a>, objectTitle=NEJM：每日一次Relugolix联合疗法治疗子宫肌瘤的III期临床试验, objectType=article, longId=207256, objectId=1d0f20e25662, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1d0f20e25662, replyNumber=0, likeNumber=54, createdTime=2021-02-20, rootId=0, userName=juliusluan83, userId=caea15855208, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1d0f20e25662, moduleTitle=NEJM：每日一次Relugolix联合疗法治疗子宫肌瘤的III期临床试验, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1d0f20e25662)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1573350, encodeId=e13215e335008, content=<a href='/topic/show?id=b70f1530138' target=_blank style='color:#2F92EE;'>#relugolix#</a>, objectTitle=NEJM：Relugolix联合疗法治疗子宫肌瘤, objectType=article, longId=207255, objectId=f8f020e25546, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f8f020e25546, replyNumber=0, likeNumber=80, createdTime=2021-02-20, rootId=0, userName=juliusluan83, userId=caea15855208, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f8f020e25546, moduleTitle=NEJM：Relugolix联合疗法治疗子宫肌瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f8f020e25546)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1573349, encodeId=73c715e334925, content=<a href='/topic/show?id=b70f1530138' target=_blank style='color:#2F92EE;'>#relugolix#</a>, objectTitle=Relugolix治疗子宫内膜异位症疼痛：III期研究达到所有关键终点, objectType=article, longId=196391, objectId=06ff19639198, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=06ff19639198, replyNumber=0, likeNumber=79, createdTime=2020-06-25, rootId=0, userName=juliusluan83, userId=caea15855208, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=06ff19639198, moduleTitle=Relugolix治疗子宫内膜异位症疼痛：III期研究达到所有关键终点, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=06ff19639198)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1573348, encodeId=d79f15e334875, content=<a href='/topic/show?id=b70f1530138' target=_blank style='color:#2F92EE;'>#relugolix#</a>, objectTitle=NEJM：口服Relugolix治疗晚期前列腺癌, objectType=article, longId=195325, objectId=cf7a19532502, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cf7a19532502, replyNumber=0, likeNumber=72, createdTime=2020-06-06, rootId=0, userName=juliusluan83, userId=caea15855208, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cf7a19532502, moduleTitle=NEJM：口服Relugolix治疗晚期前列腺癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cf7a19532502)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1573347, encodeId=46b715e3347fa, content=<a href='/topic/show?id=b70f1530138' target=_blank style='color:#2F92EE;'>#relugolix#</a>, objectTitle=3期临床研究证实，促性腺激素释放激素（GnRH）受体拮抗剂Relugolix 显着减轻子宫内膜异位症女性的疼痛, objectType=article, longId=192962, objectId=cdb5192962b6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cdb5192962b6, replyNumber=0, likeNumber=65, createdTime=2020-04-27, rootId=0, userName=juliusluan83, userId=caea15855208, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cdb5192962b6, moduleTitle=3期临床研究证实，促性腺激素释放激素（GnRH）受体拮抗剂Relugolix 显着减轻子宫内膜异位症女性的疼痛, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cdb5192962b6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1573346, encodeId=dafa15e3346af, content=<a href='/topic/show?id=b70f1530138' target=_blank style='color:#2F92EE;'>#relugolix#</a>, objectTitle=Myovant Sciences向欧洲药品管理局提交了Relugolix联合片剂治疗子宫肌瘤的上市许可申请, objectType=article, longId=189703, objectId=49a0189e030c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=49a0189e030c, replyNumber=0, likeNumber=71, createdTime=2020-03-12, rootId=0, userName=juliusluan83, userId=caea15855208, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=49a0189e030c, moduleTitle=Myovant Sciences向欧洲药品管理局提交了Relugolix联合片剂治疗子宫肌瘤的上市许可申请, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=49a0189e030c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1573345, encodeId=b2ff15e3345a6, content=<a href='/topic/show?id=b70f1530138' target=_blank style='color:#2F92EE;'>#relugolix#</a>, objectTitle=Myovant口服促性腺激素释放激素拮抗剂relugolix的前列腺癌III期试验成功, objectType=article, longId=183428, objectId=910418342888, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=910418342888, replyNumber=0, likeNumber=69, createdTime=2019-11-24, rootId=0, userName=juliusluan83, userId=caea15855208, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=910418342888, moduleTitle=Myovant口服促性腺激素释放激素拮抗剂relugolix的前列腺癌III期试验成功, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=910418342888)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

relugolix

2020-05-29

梅斯管理员 (审核中...)

前往app查看评论内容

#子宫肌瘤# #月经过多# #relugolix#

LIBERTY随机停药研究：relugolix联合疗法治疗子宫肌瘤相关月经量过多

2023-11-26

juliusluan83 (审核中...)

前往app查看评论内容

#relugolix#

NEJM：Relugolix联合疗法治疗子宫肌瘤

2021-12-30

juliusluan83 (审核中...)

前往app查看评论内容

#relugolix#

子宫肌瘤，Relugolix治疗子宫肌瘤显示出潜在的长期益处

2021-12-30

juliusluan83 (审核中...)

前往app查看评论内容

#relugolix#

子宫肌瘤，Relugolix治疗子宫肌瘤显示出潜在的长期益处

2021-03-29

juliusluan83 (审核中...)

前往app查看评论内容

#relugolix#

NEJM：每日一次Relugolix联合疗法治疗子宫肌瘤的III期临床试验

2021-02-20

juliusluan83 (审核中...)

前往app查看评论内容

#relugolix#

NEJM：Relugolix联合疗法治疗子宫肌瘤

2021-02-20

juliusluan83 (审核中...)

前往app查看评论内容

#relugolix#

Relugolix治疗子宫内膜异位症疼痛：III期研究达到所有关键终点

2020-06-25

juliusluan83 (审核中...)

前往app查看评论内容

#relugolix#

NEJM：口服Relugolix治疗晚期前列腺癌

2020-06-06

juliusluan83 (审核中...)

前往app查看评论内容

#relugolix#

3期临床研究证实，促性腺激素释放激素（GnRH）受体拮抗剂Relugolix 显着减轻子宫内膜异位症女性的疼痛

2020-04-27

juliusluan83 (审核中...)

前往app查看评论内容

#relugolix#

Myovant Sciences向欧洲药品管理局提交了Relugolix联合片剂治疗子宫肌瘤的上市许可申请

2020-03-12

juliusluan83 (审核中...)

前往app查看评论内容

#relugolix#

Myovant口服促性腺激素释放激素拮抗剂relugolix的前列腺癌III期试验成功

2019-11-24

科室
- - 订阅+
  - 更多科室
工具
服务